Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027
CMS tweaked its CE, documentation, and on-site visit requirements for directors
Third-party verification of lab personnel experience is now a CLIA requirement
However, a proposed bill called the RESULTS Act is racing to thwart the cuts to lab test reimbursement rates
Clinical labs gain flexibility in meeting regulatory standards while potentially reducing their costs
Washington State’s Department of Health details how its medical testing site program meets federal standards
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests